Pharmaceuticals

Mutation Detection Kits In Genome Editing Market Expected to Show Steady Growth, Approaching $2.1 Billion by 2030

March 23, 2026March 23, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Expected For The Mutation Detection Kits In Genome Editing Market At The End Of The 2026–2030 Forecast Period?

The mutation detection kits in genome editing market size has seen substantial growth in recent years. This market is projected to expand from $1.14 billion in 2025 to $1.29 billion by 2026, achieving a compound annual growth rate (CAGR) of 13.2%. Historically, the growth can be attributed to the limited availability of mutation detection kits, reliance on manual and traditional detection techniques, expanding genome editing research, an increasing demand for precise validation tools, and the adoption of basic nucleic acid reagents.

The mutation detection kits in genome editing market size is projected to experience swift expansion in the coming years. It is anticipated to grow to $2.1 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 13.0%. The growth during the forecast period is attributable to the development of advanced CRISPR-based mutation validation kits, rising investment in next-generation sequencing technologies, the expansion of cloud-based bioinformatics solutions, increasing applications in clinical diagnostics and personalized medicine, and the integration of AI-driven data interpretation tools. Major trends expected in this period include the rising adoption of PCR-based and next-generation sequencing mutation detection kits, the increasing use of CRISPR mutation validation tools in genome editing research, growth in software solutions for genomic data analysis and visualization, the expansion of mutation detection applications in drug development and clinical diagnostics, and the integration of cloud-based bioinformatics platforms for real-time data interpretation.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27356&type=smp

What Major Growth Drivers Are Shaping The Outlook Of The Mutation Detection Kits In Genome Editing Market?

The increasing occurrence of genetic disorders is projected to propel the growth of mutation detection kits within the genome editing market in the future. Genetic disorders are defined as illnesses or conditions resulting from irregularities in an individual’s DNA, which may be inherited from parents or manifest due to new genetic mutations. The rise in these disorders is driven by greater public awareness and advanced diagnostic technologies, which facilitate earlier and more accurate identification of conditions, consequently leading to higher reported prevalence rates. Genome editing mutation detection kits play a vital role in addressing genetic disorders by precisely identifying disease-causing gene mutations, thereby enabling focused research and the creation of accurate therapeutic interventions. For instance, in May 2024, according to the National Health Service, a UK-based government department, approximately 17,000 people in England live with sickle cell disease, an inherited blood disorder, with around 250 new cases diagnosed each year. Consequently, the growing prevalence of genetic disorders is a key driver for the expansion of mutation detection kits in the genome editing market.

What Segment Types Make Up The Mutation Detection Kits In Genome Editing Market?

The mutation detection kits in genome editing market covered in this report is segmented –

1) By Product Type: Reagents, Kits, Software Solutions

2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Transcription Activator-Like Effector Nucleases Or Meganuclease-TAL Effector Nucleases (TALENs/MegaTALs), Zinc Finger Nucleases (ZFN), Other Technologies

3) By Application: Research, Clinical Diagnostics, Drug Development, Other Applications

4) By End Use: Academic Institutions, Hospitals And Diagnostic Centers, Biotechnology Companies

Subsegments:

1) By Reagents: Deoxyribonucleic Acid Polymerases (DNA) Polymerases, Nucleases, Buffers And Enzymes, Fluorescent Dyes And Probes, Primers And Oligonucleotides

2) By Kits: Polymerase Chain Reaction (PCR)-Based Mutation Detection Kits, Next-Generation Sequencing-Based Mutation Analysis Kits, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Mutation Validation Kits, Gel Electrophoresis-Based Detection Kits

3) By Software Solutions: Mutation Analysis And Visualization Tools, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) Off-Target Prediction Software, Genomic Alignment and Annotation Software, Data Interpretation Platforms For Next-Generation Sequencing, Cloud-Based Bioinformatics Platforms

Which Market Trends Are Creating New Opportunities In The Mutation Detection Kits In Genome Editing Market?

Major companies engaged in the mutation detection kits segment of the genome editing market are focusing on the development of advanced products, such as ultrasensitive multiplexed assays, to improve the accuracy, speed, and sensitivity of genetic mutation detection. Ultrasensitive multiplexed assays are sophisticated diagnostic tests designed to concurrently detect and measure multiple genetic mutations, even at very low concentrations, which assists researchers and clinicians in achieving faster, more precise, and comprehensive mutation analysis for enhanced disease diagnosis and treatment monitoring. For example, in April 2024, Bio-Rad Laboratories Inc., a US-based research company, launched the ddPLEX ESR1 Mutation Detection Kit, an ultrasensitive multiplexed digital PCR assay specifically developed for breast cancer mutation detection. This kit facilitates the simultaneous identification and accurate quantification of seven ESR1 mutations, offering an analytical sensitivity as low as 0.01% variant allele fraction, and supports analysis of both plasma and tissue samples. Such product innovations highlight the industry’s dedication to improving diagnostic precision and enabling more effective disease monitoring and personalized treatment approaches.

Who Are The Key Players Driving Competition In The Mutation Detection Kits In Genome Editing Market?

Major companies operating in the mutation detection kits in genome editing market are F. Hoffmann-La Roche Ltd, Merck KGaA, Thermo Fisher Scientific Inc., QIAGEN N.V., Eurofins Scientific SE, Agilent Technologies Inc., Illumina Inc., Bio-Rad Laboratories Inc., Integrated DNA Technologies Inc., GenScript Biotech Corporation, Takara Bio Inc., Promega Corporation, Analytik Jena AG, Twist Bioscience Corporation, New England Biolabs Inc., Applied Biological Materials Inc., Synthego Corporation, BioVision Inc., Creative Biogene Corporation

Read the full mutation detection kits in genome editing market report here:

https://www.thebusinessresearchcompany.com/report/mutation-detection-kits-in-genome-editing-global-market-report

Which Regions Are Projected To Dominate The Mutation Detection Kits In Genome Editing Market In The Coming Years?

North America was the largest region in the mutation detection kits in genome editing market in 2025. Asia‑Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mutation detection kits in genome editing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Mutation Detection Kits In Genome Editing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27356&type=smp

Browse Through More Reports Similar to the Global Mutation Detection Kits In Genome Editing Market 2026, By The Business Research Company

Pet Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-insurance-global-market-report

Pet Healthcare Market Report 2026

https://www.thebusinessresearchcompany.com/report/pet-healthcare-global-market-report

Accidental Death Insurance Market Report 2026

https://www.thebusinessresearchcompany.com/report/accidental-death-insurance-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795